ArticleClinical kidney journal2025
Regional citrate anticoagulation algorithm and management protocol aimed at ensuring blood calcium stability: a prospective single-arm study.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ionized hypocalcemia prior to continuous veno-venous hemodialysis initiation: prevalence and consequences.BMC anesthesiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although several regional citrate anticoagulation (RCA) algorithms have been reported, clinical data confirming their effectiveness and safety are limited. We have developed a novel RCA algorithm applicable to extensive continuous renal replacement therapy (CRRT) settings. The aims of this study were to evaluate the incidence of calcium and citrate abnormalities that necessitated human intervention when using this algorithm during RCA and to identify the optimal values of the coefficients Methods: We conducted a prospective, single-arm study in patients who underwent RCA using various CRRT modes and parameters, calcium-containing replacement fluids, and presession blood calcium abnormalities. The primary outcome was the incidence of citrate and calcium overdose and deficiency in the absence of human intervention. Secondary outcomes included the values of Results: A total of 282 RCA sessions in 110 patients were investigated. The incidence of citrate and calcium abnormalities was 19.5% (55/282). In the low-dose citrate sessions, citrate overdose occurred in one session (1/148), while the incidence of citrate deficiency was 22.3% (33/148). In the high-dose citrate sessions, citrate deficiency occurred in two sessions (2/134) and citrate overdose occurred in 18/134 (13.4%) sessions. One session (1/282) of calcium overdose was also observed, whereas no calcium deficiency occurred during RCA. Conclusions: The application of this innovative RCA algorithm to sessions involving various CRRT conditions markedly decreased the incidence of citrate and calcium abnormalities. As a consequence, this reduction minimized the necessity for modifications to the rate of calcium and citrate supplementation during RCA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.